Multileaf Collimator Field Research Articles

Characterization of a novel VenusX orthogonal dual-layer multileaf collimator.

To investigate and characterize the performance of a novel orthogonal dual-layer alpha multileaf collimator (αMLC) mounted on the LinaTech VenusX linac. We evaluated leaf positioning accuracy and reproducibility using an electronic portal imaging device through the picket fence test. The average, interleaf, intraleaf, and leaf tip transmissions of the single and dual layers were measured using an ionization chamber. Square and rhombus fields were used to evaluate the leaf penumbra of αMLC. To investigate the advantages of the orthogonal dual-layer multileaf collimator (MLC) in field shaping, right triangular and circular pattern fields were formed using both the dual layers and single layers of the αMLC. The average maximum positioning deviations of the upper and lower αMLC over 1 year were 0.76±0.09mm and 0.62±0.07mm, respectively. The average transmissions were 1.87%, 1.83%, and 0.03% for the upper-, lower- and dual-layer αMLC, respectively. The maximum interleaf transmissions of the lower- and dual-layer were 2.43% and 0.17%, respectively. The leaf tip transmissions were 9.34% and 0.25%, respectively. The penumbra of the square field was 6.2mm in the X direction and 8.0mm in the Y direction. The average penumbras of the rhombus fields with side lengths of 5 and 10cm were 3.6 and 4.9mm, respectively. For the right triangular and circular fields, the fields shaped by the dual-layer leaves were much closer to the set field than those shaped by single-layer leaves. The dose undulation amplitude of the 50% isodose lines and leaf stepping angle change of the dual-layer leaves were smaller than those of the single-layer leaves. The αMLC benefits from its orthogonal dual-layer design. Leaf transmission, dose undulations at the field edge, and MLC field dependence of the leaf stepping angle of the dual-layer αMLC were remarkably reduced.

Rapid calibration curve generation using single-sheet radiochromic film for proton-based stereotactic radiosurgery verification

Proton-based stereotactic radiosurgery (PSRS) holds promise for treating benign tumours, with patient-specific quality assurance (PSQA) playing a crucial role in ensuring high-quality clinical services. EBT3 films are a perfect tool for PSQA, particularly owing to their compatibility with small-field dosimetry. However, a successful absolute EBT3 dosimetry relies on detailed dose calibration, consuming much time and films. A novel approach has been developed in this study and tested to establish a calibration curve using a single sheet of EBT3 radiochromic films exposed to six multi-leaf collimator (MLC) fields. Notably, this method allows for the completion of a calibration curve in just 15 min, enabling the practical generation of new EBT3 calibrations daily. This single-sheet approach can generate a dose calibration curve with an error of less than 1.5% across the entire dose range and is well agreed to by traditional multi-film calibrations involving large fields, with a discrepancy of less than 0.8%.

Viability of the virtual cone technique using a fixed small multi-leaf collimator field for stereotactic radiosurgery of trigeminal neuralgia.

Dosimetric uncertainties in very small (≤1.5×1.5 cm2 ) photon fields are remarkably higher, which undermines the validity of the virtual cone (VC) technique with a diminutive and variable MLC fields. We evaluate the accuracy and reproducibility of the VC method with a very small, fixed MLC field setting, called a fixed virtual cone (fVC), for small target radiosurgery such as trigeminal neuralgia (TGN). The fVC is characterized by 0.5 cm x 0.5cm high-definition (HD) MLC field of 10MV FFF beam defined at 100cm SAD, while backup jaws are positioned at 1.5 cm x 1.5cm. A spherical dose distribution equivalent to 5mm (diameter) physical cone was generated using 10-14 non-coplanar, partial arcs. Dosimetric accuracy was validated using SRS diode (PTW 60018), SRS MapCHECK (SNC) measurements. As a quality assurance measure, 10 treatment plans (SRS) for TGN, consisting of various arc ranges at different collimator angles were analyzed using 6 MV FFF and 10 MV FFF beams, including a field-by-field study (n=130 fields). Dose outputs were compared between the Eclipse TPS and measurements (SRS MapCHECK). Moreover, dosimetric changes in the field defining fVC, prompted by a minute (±0.5-1.0mm) leaf shift, was examined among TPS, diode measurements, and Monte Carlo (MC) simulations. The beam model for fVC was validated (≤3% difference) using SRS MapCHECK based absolute dose measurements. The equivalent diameters of the 50% isodose distribution were found comparable to that of a 5mm cone. Additionally, the comparison of field output factors, dose per MU between the TPS and SRS diode measurements using the fVC field, including±1mm leaf shift, yielded average discrepancies within 5.5% and 3.5% for 6 MV FFF and 10 MV FFF beams, respectively. Overall, the fVC method is a credible alternative to the physical cone (5mm) that can be applied in routine radiosurgical treatment of TGN.

A convolution-superposition fluence model for the Siemens HD120 multi leaf collimator with application to a 3D VMAT dose engine

Purpose. To construct a fast-calculating fluence modelfor the Siemens HD120 multi leaf collimator (MLC) using convolution-superposition techniques, and to develop a 3D VMAT dose engine using this fluence model. This work offers analternative to time-consuming open-source Monte Carlo simulations for thosedeveloping in-house dose-calculating software for research or clinical needs.Methods. EPID-acquired images of sweeping-window and sweeping-checker field profiles were used to commission transmission, 2 Dinterleaf leakage, and tongue-and-groove maps specific to the HD120 MLC. These maps, along with a 2D head-scattermodel were incorporated into a convolution-superposition algorithm to provide a fluence model for the HD120 MLC. This fluence model was used to develop a 3D VMAT dose engine, where 3D pre-computed 6MV dose kernels (EGSnrc) and a 3D fluence curvature-correction map were incorporatedto calculate 3D VMAT doses in a 22 cm diameter cylindrical phantom. Four VMAT patient plans witha large range of PTV sizes (36 cc to 604 cc) were chosen to test the fluence model and dose engine. Results. Excellent agreement was observed between the simulated commissioning fields and measured EPID-responses. 2D 2%/2 mm gamma analysis yielded a 98.9% pass rate for 1 cm, 2 cm, and 4 cm sweeping-window fields. 2D 2%/2mm gamma analysis for outer/inner MLC leaves yielded 89.1%/77.0% and 95.2%/91.1% pass rates from 1 cm and 2 cm sweeping-checker fields. Mean 3%/3 mm gamma analysis showed excellent agreement between our dose engine and Eclipse (Acuros) regardless of PTV size: 98.7% pass rate, with 95.1% pass rate in the high-dose volume. Fluence calculation times were13.6 seconds per dynamic MLC field and 1.4 minutes/arc for 3D VMAT dose on a standard PC. Conclusions. A fast-calculating convolution-superposition fluence model has been commissioned for the Siemens HD120 MLC and incorporatedinto a 3D VMAT dose engine. This work can be used to facilitate the development of fast in-house dose-calculating software.

Monte Carlo modeling of Halcyon and Ethos radiotherapy beam using CAD geometry: validation and IAEA-compliant phase space

Objective. A Monte Carlo (MC) model of a Halcyon and Ethos (Varian Medical Systems, a Siemens Healthineers Company) radiotherapy beam was validated and field-independent phase space (PHSP) files were recorded above the dual-layer multileaf collimators (MLC). Approach. The treatment head geometry was modeled according to engineering drawings and the dual-layer MLC was imported from CAD (computer-aided design) files. The information for the incident electron beam was achieved from an iterative electromagnetic solver. The validation of the model was performed by comparing the dose delivered by the square MLC fields as well as complex field measurements. Main results. An electron phase space was generated from linac simulations and achieved improved MC results. The output factors for square fields were within 1% and the largest differences of 5% were found in the build-up region of PDDs and the penumbra region of profiles. With the more complicated MLC-shaped field (Fishbone), the largest differences of up to 8% were found in the MLC leaf tip region due to the uncertainty of the MLC positioning and the mechanical leaf gap value. The impact of the collimator rotation on the PHSP solution has been assessed with both small and large fields, confirming negligible effects on in-field and out-of-field dose distributions. Significance. A computational model of the Halcyon and Ethos radiotherapy beam with a high accuracy implementation of the MLC was shown to be able to reproduce the radiation beam characteristics with square fields and more complex MLC-shaped fields. The field-independent PHSP files that were produced can be used as an accurate treatment head model above the MLC, and reduce the time to simulate particle transport through treatment head components.

A novel Monte Carlo (MC) dose model for small MLC fields of the cyberknife® M6TM radiosurgery system using the EGSnrc.

The multi-leaf collimator (MLC)-equipped CyberKnife® M6 radiosurgery system (CKM6) (Accuray Inc., Sunnyvale, CA) has been increasingly employed for stereotactic radiosurgery (SRS) to treat relatively small lesions. However, achieving an accurate dose distribution in such cases is usually challenging due to the combination of numerous small fields≤(30×30)mm2 . In this study, we developed a new Monte Carlo (MC) dose model for the CKM6 system using the EGSnrc to investigate dose variations in the small fields. The dose model was verified for the static MLC fields ranging from (53.8×53.9) to (7.6×7.7) mm2 at 800mm source to axis distance in a water phantom, based on the computed doses of Accuray Precision® (Accuray Inc.) treatment planning system (TPS). We achieved a statistical uncertainty of ≤4% by simulating 30-50 million incident particles/histories. Then, the treatment plans were created for the same fields in the TPS, and the corresponding measurements were performed with MapCHECK2 (Sun Nuclear Corporation), a standard device for patient-specific quality assurance (PSQA). Results of the MC simulations, TPS, and MapCHECK2 measurements were inter-compared. An overall difference in dosimetric parameters such as profiles, tissue maximum ratio (TMR), and output factors (OF) between the MC simulations and the TPS results was found ≤3% for (53.8×53.9-15.4×15.4) mm2 MLC fields, and it rose to 4.5% for the smallest (7.6mm×7.7mm) MLC field. The MapCHECK2 results showed a deviation ranging from -1.5% to + 4.5% compared to the TPS results, whereas the deviation was within±2.5% compared with the MC results. Overall, our MC dose model for the CKM6 system showed better agreement with measurements and it could serve as a secondary dose verification tool for the patient-specific QA in small fields.

Small-field dosimetry with detector-specific output correction factor for single-isocenter stereotactic radiotherapy of single and multiple brain metastases.

Recently, the International Atomic Energy Agency and the American Association of Physicists in Medicine reported correction factors (CFs) for detector-response variation considering the uncertainty in detector readings in small-field dosimetry. In this study, the effect of CFs on small-field dosimetry measurements was evaluated for single-isocenter stereotactic radiotherapy for brain metastases. The output factors (OPFs) were measured with and without CFs in a water-equivalent sphere phantom using TrueBeam with a flattening-filter-free energy of 10 MV. Five detectors were used in a perpendicular orientation: CC01, 3D pinpoint ionization chambers, unshielded SFD detector, shielded EDGE detector, and microDiamond detector. First, the square-field sizes were set to 5-100mm using a multi-leaf collimator (MLC) field. The OPFs were evaluated in the presence and absence of CFs. Second, single-isocenter stereotactic irradiation was performed on 22 brain metastases in 15 patients following dynamic conformal arc (DCA) treatment. The equivalent field size was calculated using the MLC aperture for each planning target volume. For the OPFs, the mean deviations from the median of the doses measured with detectors other than the CC01 for square-field sizes larger than 10mm were within ± 4.3% of the median without CFs, and ± 3.3% with CFs. For DCA plans, the deviations without and with CFs were -2.3 ± 1.9% and -4.8 ± 2.4% for CC01, -1.1 ± 3.0% and 1.0 ± 1.6% for 3D pinpoint, 8.8 ± 3.0% and 2.9 ± 2.8% for SFD, -3.1 ± 3.0% and -13.5 ± 4.0% for EDGE, and 8.9 ± 2.1% and 0.8 ± 1.9% for microDiamond. This feasibility study confirmed that the deviation of the detectors can be reduced using an appropriate detector with CFs.

A fast GPU-accelerated Monte Carlo engine for calculation of MLC-collimated electron fields.

Although intensity-modulated radiation therapy and volumetric arc therapy have revolutionized photon external beam therapies, the technological advances associated with electron beam therapy have fallen behind. Modern linear accelerators contain technologies that would allow for more advanced forms of electron treatments, such as beam collimation, using the conventional photon multi-leaf collimator (MLC); however, no commercial solutions exist that calculate dose from such beam delivery modes. Additionally, for clinical adoption to occur, dose calculation times would need to be on par with that of modern dose calculation algorithms. This work developed a graphics processing unit (GPU)-accelerated Monte Carlo (MC) engine incorporating the Varian TrueBeam linac head geometry for a rapid calculation of electron beams collimated using the conventional photon MLC. A compute unified device architecture framework was created for the following: (1) transport of electrons and photons through the linac head geometry, considering multiple scattering, Bremsstrahlung, Møller, Compton, and pair production interactions; (2) electron and photon propagation through the CT geometry, considering all interactions plus the photoelectric effect; and (3) secondary particle cascades through the linac head and within the CT geometry. The linac head collimating geometry was modeled according to the specifications provided by the vendor, who also provided phase-space files. The MC was benchmarked against EGSnrc/DOSXYZnrc/GEANT by simulating individual interactions with simple geometries, pencil, and square beam dose calculations in various phantoms. MC-calculated dose distributions for MLC and jaw-collimated electron fields were compared to measurements in a water phantom and with radiochromic film. Pencil and square beam dose distributions are in good agreement with DOSXYZnrc. Angular and spatial distributions for multiple scattering and secondary particle production in thin slab geometries are in good agreement with EGSnrc and GEANT. Dose profiles for MLC and jaw-collimated 6-20-MeV electron beams showed an average absolute difference of 1.1 and 1.9mm for the FWHM and 80%-20% penumbra from measured profiles. Percent depth doses showed differences of <5% for as compared to measurement. The computation time on an NVIDIA Tesla V100 card was 2.5min to achieve a dose uncertainty of <1%, which is ∼300 times faster than published results in a similar geometry using a single-CPU core. The GPU-based MC can quickly calculate dose for electron fields collimated using the conventional photon MLC. The fast calculation times will allow for a rapid calculation of electron fields for mixed photon and electron particle therapy.

Commissioning an Exradin W2 plastic scintillation detector for clinical use in small radiation fields.

PurposeThe purpose of this work is to evaluate the Standard Imaging Exradin W2 plastic scintillation detector (W2) for use in the types of fields used for stereotactic radiosurgery.MethodsPrior to testing the W2 in small fields, the W2 was evaluated in standard large field conditions to ensure good detector performance. These tests included energy dependence, short‐term repeatability, dose‐response linearity, angular dependence, temperature dependence, and dose rate dependence. Next, scan settings and calibration of the W2 were optimized to ensure high quality data acquisition. Profiles of small fields shaped by cones and multi‐leaf collimator (MLCs) were measured using the W2 and IBA RAZOR diode in a scanning water tank. Output factors for cones (4–17.5 mm) and MLC fields (1, 2, 3 cm) were acquired with both detectors. Finally, the dose at isocenter for seven radiosurgery plans was measured with the W2 detector.ResultsW2 exhibited acceptable warm‐up behavior, short‐term reproducibility, axial angular dependence, dose‐rate linearity, and dose linearity. The detector exhibits a dependence upon energy, polar angle, and temperature. Scanning measurements taken with the W2 and RAZOR were in good agreement, with full‐width half‐maximum and penumbra widths agreeing to within 0.1 mm. The output factors measured by the W2 and RAZOR exhibited a maximum difference of 1.8%. For the seven point‐dose measurements of radiosurgery plans, the W2 agreed well with our treatment planning system with a maximum deviation of 2.2%. The Čerenkov light ratio calibration method did not significantly impact the measurement of relative profiles, output factors, or point dose measurements.ConclusionThe W2 demonstrated dosimetric characteristics that are suitable for radiosurgery field measurements. The detector agreed well with the RAZOR diode for output factors and scanned profiles and showed good agreement with the treatment planning system in measurements of clinical treatment plans.

Practical Dosimetry Considerations for Small MLC-Shaped Electron Fields at 60 cm SSD.

Superficial tumours can be treated with megavoltage electron beams. The underlying tissue can be spared through the steep dose fall-off gradients over a range of a few centimetres. An accurate Monte Carlo model for an Elekta Precise was determined and dose distribution was simulated. Dosimetric parameters were calculated to set guidelines for tumour irradiation. Elekta Precise multi-leaf collimators (MLC), which shaped electron fields were investigated using a benchmarked Monte Carlo model. BEAMnrc modelled the Elekta Precise and results were benchmarked against measurements. Percentage depth dose and beam profile data were simulated within 2% / 2 mm accuracy of the measured data. The DOSXYZnrc code simulated the 3-D dose data in water between 4 and 15 MeV. The relative (P80-20) penumbra, percentage depth dose (PDD), range to 90% of dose maximum (R90), dose fall-off range R80-20 (DFR), and the percentage bremsstrahlung dose (BSD), were extracted from the simulated data. The relative penumbra ranged from 90% to 10% at 6 MeV and 15 MeV, respectively. R90 values ranged between 0.8 cm at 4 MeV and 4.5 cm at 15 MeV. The DFR ranged between 0.8 cm at 4 MeV and 3.5 cm at 15 MeV. The BSD was the highest for low beam energies and small fields. Developed guidelines indicated that intermediate-sized MLC fields are most suited for therapy since they have lower BSD, longer R90, shorter DFR but larger P80-20. The DFR increases and R90 decreases for small fields at higher beam energies and more distal tissue will receive doses > 20%.

DeepWL: Robust EPID based Winston-Lutz analysis using deep learning, synthetic image generation and optical path-tracing.

Radiation therapy requires clinical linear accelerators to be mechanically and dosimetrically calibrated to a high standard. One important quality assurance test is the Winston-Lutz test which localises the radiation isocentre of the linac. In the current work we demonstrate a novel method of analysing EPID based Winston-Lutz QA images using a deep learning model trained only on synthetic image data. In addition, we propose a novel method of generating the synthetic WL images and associated 'ground-truth' masks using an optical path-tracing engine to 'fake' mega-voltage EPID images. The model called DeepWL was trained on 1500 synthetic WL images using data augmentation techniques for 180 epochs. The model was built using Keras with a TensorFlow backend on an Intel Core i5-6500T CPU and trained in approximately 15h. DeepWL was shown to produce ball bearing and multi-leaf collimator field segmentations with a mean dice coefficient of 0.964 and 0.994 respectively on previously unseen synthetic testing data. When DeepWL was applied to WL data measured on an EPID, the predicted mean displacements were shown to be statistically similar to the Canny Edge detection method. However, the DeepWL predictions for the ball bearing locations were shown to correlate better with manual annotations compared with the Canny edge detection algorithm. DeepWL was demonstrated to analyse Winston-Lutz images with an accuracy suitable for routine linac quality assurance with some statistical evidence that it may outperform Canny Edge detection methods in terms of segmentation robustness and the resultant displacement predictions.

Intrinsic detector sensitivity analysis as a tool to characterize ArcCHECK and EPID sensitivity to variations in delivery for lung SBRT VMAT plans.

PurposeTo investigate intrinsic sensitivity of an electronic portal imaging device (EPID) and the ArcCHECK detector and to use this in assessing their performance in detecting delivery variations for lung SBRT VMAT. The effect of detector spatial resolution and dose matrix interpolation on the gamma pass rate was also considered.Materials and methodsFifteen patients’ lung SBRT VMAT plans were used. Delivery variations (errors) were introduced by modifying collimator angles, multi‐leaf collimator (MLC) field sizes and MLC field shifts by ±5, ±2, and ±1 degrees or mm (investigating 103 plans in total). EPID and ArcCHECK measured signals with introduced variations were compared to measured signals without variations (baseline), using OmniPro‐I'mRT software and gamma criteria of 3%/3 mm, 2%/2 mm, 2%/1 mm, and 1%/1 mm, to test each system's basic performance. The measurement sampling resolution for each was also changed to 1 mm and results compared to those with the default detector system resolution.ResultsIntrinsic detector sensitivity analysis, that is, comparing measurement to baseline measurement, rather than measurement to plan, demonstrated the intrinsic constraints of each detector and indicated the limiting performance that users might expect. Changes in the gamma pass rates for ArcCHECK, for a given introduced error, were affected only by dose difference (DD %) criteria. However, the EPID showed only slight changes when changing DD%, but greater effects when changing distance‐to‐agreement criteria. This is pertinent for lung SBRT where the minimum dose to the target will drop dramatically with geometric errors. Detector resolution and dose matrix interpolation have an impact on the gamma results for these SBRT plans and can lead to false positives or negatives in error detection if not understood.ConclusionThe intrinsic sensitivity approach may help in the selection of more meaningful gamma criteria and the choice of optimal QA device for site‐specific dose verification.

Commissioning and clinical implementation of the first commercial independent Monte Carlo 3D dose calculation to replace CyberKnife M6™ patient-specific QA measurements.

PurposeTo report on the commissioning and clinical validation of the first commercially available independent Monte Carlo (MC) three‐dimensional (3D) dose calculation for CyberKnife robotic radiosurgery system® (Accuray, Sunnyvale, CA).MethodsThe independent dose calculation (IDC) by SciMoCa® (Scientific RT, Munich, Germany) was validated based on water measurements of output factors and dose profiles (unshielded diode, field‐size dependent corrections). A set of 84 patient‐specific quality assurance (QA) measurements for multi‐leaf collimator (MLC) plans, using an Octavius two‐dimensional SRS1000 array (PTW, Freiburg, Germany), was compared to results of respective calculations. Statistical process control (SPC) was used to detect plans outside action levels.ResultsOf all output factors for the three collimator systems of the CyberKnife, 99% agreed within 2% and 81% within 1%, with a maximum deviation of 3.2% for a 5‐mm fixed cone. The profiles were compared using a one‐dimensional gamma evaluation with 2% dose difference and 0.5 mm distance‐to‐agreement (Γ(2,0.5)). The off‐centre ratios showed an average pass rate >99% (92–100%). The agreement of the depth dose profiles depended on field size, with lowest pass rates for the smallest MLC field sizes. The average depth dose pass rate was 88% (35–99%). The IDCs showed a Γ(2,1) pass rate of 98%. Statistical process control detected six plans outside tolerance levels in the measurements, all of which could be attributed the measurement setup. Independent dose calculations showed problems in five plans, all due to differences in the algorithm between TPS and IDC. Based on these results changes were made in the class solution for treatment plans.ConclusionThe first commercially available MC 3D dose IDC was successfully commissioned and validated for the CyberKnife and replaced all routine patient‐specific QA measurements in our clinic.

Detailed evaluation of Mobius3D dose calculation accuracy for volumetric-modulated arc therapy

PurposeTo perform a detailed evaluation of dose calculation accuracy and clinical feasibility of Mobius3D. Of particular importance, multileaf collimator (MLC) modeling accuracy in the Mobius3D dose calculation algorithm was investigated. MethodsMobius3D was fully commissioned by following the vendor-suggested procedures, including dosimetric leaf gap (DLG) optimization. The DLG optimization determined an optimal DLG correction factor which minimized the average difference between calculated and measured doses for 13 patient volumetric-modulated arc therapy (VMAT) plans. Two sets of step-and-shoot plans were created to examine MLC and off-axis open fields modeling accuracy of the Mobius3D dose calculation algorithm: MLC test set and off-axis open field test set. The test plans were delivered to MapCHECK for the MLC tests and an ionization chamber for the off-axis open field test, and these measured doses were compared to Mobius3D-calculated doses. ResultsThe mean difference between the calculated and measured doses across the 13 VMAT plans was 0.6% with an optimal DLG correction factor of 1.0. The mean percentage of pixels passing gamma from a 3%/1 mm gamma analysis for the MLC test set was 43.5% across the MLC tests. For the off-axis open field tests, the Mobius3D-calculated dose for 1.5 cm square field was −4.6% lower than the chamber-measured dose. ConclusionsIt was demonstrated that Mobius3D has dose calculation uncertainties for small fields and MLC tongue-and-groove design is not adequately taken into consideration in Mobius3D. Careful consideration of DLG correction factor, which affects the resulting dose distributions, is required when commissioning Mobius3D for patient-specific QA.

Validation of PRIMO Monte Carlo Model of Clinac®iX 6MV Photon Beam.

Purpose:This study aims to model 6MV photon of Clinac®iX linear accelerator using PRIMO Monte Carlo (MC) code and to assess PRIMO as an independent MC-based dose verification and quality assurance tool.Materials and Methods:The modeling of Clinac®iX linear accelerator has been carried out by using PRIMO simulation software (Version 0.3.1.1681). The simulated beam parameters were compared against the measured beam data of the Clinac®iX machine. The PRIMO simulation model of Clinac®iX was also validated against Eclipse® Acuros XB dose calculations in the case of both homogenous and inhomogeneous mediums. The gamma analysis method with the acceptance criteria of 2%, 2 mm was used for the comparison of dose distributions.Results:Gamma analysis shows a minimum pass percentage of 99% for depth dose curves and 95.4% for beam profiles. The beam quality index and output factors and absolute point dose show good agreement with measurements. The validation of PRIMO dose calculations, in both homogeneous and inhomogeneous medium, against Acuros® XB shows a minimum gamma analysis pass rate of 99%.Conclusions:This study shows that the research software PRIMO can be used as a treatment planning system-independent quality assurance and dose verification tool in daily clinical practice. Further validation will be performed with different energies, complex multileaf collimators fields, and with dynamic treatment fields.

Feasibility of virtual starshot analysis providing submillimeter radiation isocenter accuracy: A long-term multi-institutional analysis.

PurposeWe developed a technique to calculate the offset between room lasers and the radiation isocenter using a digital Winston–Lutz (WL) test with a starshot technique. We have performed isocenter localization quality assurance (QA) with submillimeter accuracy for a long period. Here we evaluated the feasibility and accuracy of this virtual starshot (VS) analysis for isocenter localization QA.MethodsA 6‐MV photon beam with a square multileaf collimator field was used to irradiate a WL sphere positioned at the intersection of the room lasers. Images were acquired using an electronic portal imaging device. A four‐field WL test was performed, and the path of each beam was calculated from the offset between the beam and sphere. Virtual starshot analysis was used to analyze the radiation isocenter, which calculates the center of the beam paths by using a least‐squares method, similar to the starshot analysis. Then, eight coplanar and 12 noncoplanar beams were irradiated to evaluate isocenter localization accuracy.ResultsSeveral VS analyses, using different WL spheres, were performed at three institutions, and the calculated accuracies were within 0.1 mm at all institutions. Long‐term analysis showed that the isocenter localization accuracy was appropriately managed with three‐dimensional accuracy within ± 0.5 mm for 90 months after the first laser adjustments. The offset between each beam and the room laser was within 0.6 mm and within 1.0 mm for eight coplanar and 12 noncoplanar beams, respectively, for 90 months. Cone‐beam computed tomography images, acquired after verification beams, showed that the offset between the radiation isocenter and the imaging center was within 0.66 mm for 90 months. The isocenter localization accuracy within 1 mm was kept for long period at other four institutions.ConclusionsLong‐term analysis showed the feasibility of VS analysis for isocenter localization QA, including room laser re‐alignment, noncoplanar irradiation verification, and image guidance accuracy.

EPID sensitivity to delivery errors for pre-treatment verification of lung SBRT VMAT plans

PurposeTo study the sensitivity of an Electronic Portal Imaging Device (EPID) in detecting delivery errors for VMAT lung stereotactic body radiotherapy (SBRT) using the Collapsed Arc method. MethodsBaseline VMAT plans and plans with errors intentionally introduced were generated for 15 lung SBRT patients. Three types of errors were introduced by modifying collimator angles and multi-leaf collimator (MLC) field sizes (MLCFS) and MLC shifts by ±5, ±2, and ±1° or millimeters. A total of 103 plans were measured with EPID on an Elekta Synergy Linear Accelerator (Agility MLC) and compared to both the original treatment planning system (TPS) Collapsed Arc dose matrix and the no-error plan baseline EPID measurements. Gamma analysis was performed using the OmniPro-I'mRT (IBA Dosimetry) software and gamma criteria of 1%/1 mm, 2%/1 mm, 2%/2 mm, and 3%/3. ResultsWhen the error-introduced EPID measured dose matrices were compared to the TPS matrices, the majority of simulated errors were detected with gamma tolerance of 2%/1 mm and 1%/1 mm. When the error-introduced EPID measured dose matrices were compared to the baseline EPID measurements, all the MLCFS and MLC shift errors, and ±5°collimator errors were detected using 2%/1 mm and 1%/1 mm gamma criteria. ConclusionThis work demonstrates the feasibility and effectiveness of the collapsed arc technique and EPID for pre-treatment verification of lung SBRT VMAT plans. The EPID was able to detect the majority of MLC and the larger collimator errors with sensitivity to errors depending on the gamma tolerances.

Development of a Geant4‐based independent patient dose validation system with an elaborate multileaf collimator simulation model

Despite the improvements in the dose calculation models of the commercial treatment planning systems (TPS), their ability to accurately predict patient dose is still limited. One of the limitations is caused by the simplified model of the multileaf collimator (MLC). The aim of this study was to develop a Monte Carlo (MC) method‐based independent patient dose validation system with an elaborate MLC model for more accurate dose evaluation. Varian Clinac 2300 IX was simulated using Geant4 toolkits, after which MC commissioning with measurements was performed to validate the simulation model. A DICOM‐RT interface was developed to obtain the beam delivery conditions including the hundreds of MLC motions. Finally, the TPS dose distributions were compared with the MC dose distributions for water phantom cases and a patient case. Our results show that the TPS overestimated the absolute abutting leakage dose in the closed MLC field, with about 20% more of the maximum dose than that of the MC calculation. For water phantom cases, the dose distributions inside the target region were almost identical with the dose difference of less than 2%, while the dose near the edge of the target shows difference about 10% between Geant4 and TPS due to geometrical differences in MLC model. For the patient analysis, the Geant4 and TPS doses of all organs were matched well within 1.4% of the prescribed dose. However, for organs located in areas with high ratio of leaf pairs with distances less than 10 mm leaf pair (LP (<10mm)), the maximum dose of TPS was overestimated by about 3% of the prescribed dose. These dose comparison results demonstrate that our system for calculating the patient dose is quite accurate. Furthermore, if the MLC sequences in treatment plan have a large ratio of LP (short), more than 3% dose difference in normal tissue could be seen.

37 Evaluation of the absorbed dose reporting mode of the AAA and AXB algorithms and the Monte-Carlo code GATE in high and low density media

Introduction The aim of our study was to investigate the dosimetric accuracy of Analytical Anisotropic Algorithm (AAA) and Acuros XB (AXB) with the two absorbed dose reporting options dose-to-medium ( D m ) and dose-to-water ( D w ) . The calculations were carried out for small multi-leaf collimator (MLC) fields in heterogeneous media against Monte Carlo (MC) simulations and EBT3 radiochromic films measurements. The well-known approach of Siebers et al.1 used for converting D m to D w in MC codes was also investigated. Methods Two multilayered slab phantoms were used for this study. These phantoms consisted of soft tissue equivalent material with bone (1.82 g/cm3) or Lung (0.29 g/cm3) slabs. MC calculations were performed using GATE platform and were considered as benchmark for D m calculations. The AXB D m calculations were compared to those of GATE D m with the AXB library elemental compositions on one hand and with the experimental phantoms elemental compositions on the other hand. The results of the AAA, AXB D w and GATE D w . were compared against film measurements considered as D w reference. All calculations and measurements were performed for 6 MV photon beams delivered from a Truebeam linear accelerator with a 3 × 3 cm2 nominal MLC field. Results The AXB D m calculations showed excellent agreement with GATE D m when the calculations were performed with the same elemental compositions. However, an average difference of 2% and 1.6% was found between AXB D m and GATE D m with the experimental phantom compositions in Lung and bone, respectively. The GATE D w and AXB D w calculations were in agreement with films measurement with an average difference less than 1.5% for the Lung configuration. Conversely, an average differences of 3.1% was found with the AAA results after the lung region. The results of AXB and GATE calculations were significantly different compared to film measurements in the bone region. Differences were up to 10.4% and 7% for AXB D w and GATE D w , respectively. These results show that the conversion method used by AXB and GATE should be reviewed. Concerning the GATE conversion method, a fluence correction factor should be applied as mentioned by Andreo [1] . This factor was calculated for the studied media and good agreements were found with measurements after applying it. Conclusions The AXB was found to be more accurate than the AAA in the low density media. The current methods employed for converting D m to D w in AXB and GATE are invalid and should be corrected. Further studies on the calculation of electron spectra and fluence correction factors in different media and for various field sizes are ongoing.

A simple method for determining dosimetric leaf gap with cross-field dose width for rounded leaf-end multileaf collimator systems

PurposeThe dosimetric leaf gap (DLG) and multileaf collimator (MLC) transmission are two important systematic parameters used to model the rounded MLC leaf ends effect when commissioning an Eclipse treatment planning system (TPS). Determining the optimal DLG is a time consuming process. This study develops a simple and reliable method for determining the DLG using the cross-field dose width.Methods and materialsA Varian TrueBeam linac with 6 MV, 10 MV, 6 MV flattening filter free (FFF) and 10 MV FFF photon beams and equipped with the 120 Millennium MLC and the Eclipse™ TPS was used in this study. Integral sliding fields and static slit MLC field doses with different gap widths were measured with an ionization chamber and GAFCHROMIC EBT3 films, respectively. Measurements were performed for different beam energies and at depths of 5 and 10 cm. DLGs were derived from a linear extrapolation to zero dose and intercepting at the gap width axis. In the ion chamber measurements method, the average MLC leaf transmission to the gap reading for each gap (RgT) were calculated with nominal and cross-field dose widths, respectively. The cross-field dose widths were determined according to the dose profile measured with EBT3 films. Additionally, the optimal DLG values were determined using plan dose measurements, as the value that produced the closest agreement between the planned and measured doses. DLGs derived from the nominal and cross-field dose width, the film measurements, and the optimal process, were obtained and compared.ResultsThe DLG values are insensitive to the variations in depth (within 0.07 mm). DLGs derived from nominal gap widths showed a significantly lower values (with difference about 0.5 mm) than that from cross-field dose widths and from film measurements and from plan optimal values. The method in deriving DLGs by correcting the nominal gap widths to the cross-field dose widths has shown good agreements to the plan optimal values (with difference within 0.21 mm).ConclusionsThe DLG values derived from the cross-field dose width method were consistent with the values derived from film measurements and from the plan optimal process. A simple and reliable method to determine DLG for rounded leaf-end MLC systems was established. This method provides a referable DLG value required during TPS commissioning.